Capital International Inc. CA lowered its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 11.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 101,749 shares of the financial services provider's stock after selling 13,332 shares during the period. Capital International Inc. CA's holdings in CME Group were worth $23,629,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently modified their holdings of CME. Dimensional Fund Advisors LP raised its position in shares of CME Group by 2.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,095,106 shares of the financial services provider's stock worth $254,314,000 after purchasing an additional 29,662 shares during the period. Capital International Ltd. CA raised its holdings in CME Group by 14.6% during the 4th quarter. Capital International Ltd. CA now owns 54,479 shares of the financial services provider's stock worth $12,652,000 after buying an additional 6,953 shares during the period. Capital Group Investment Management PTE. LTD. lifted its stake in CME Group by 12.8% in the fourth quarter. Capital Group Investment Management PTE. LTD. now owns 12,299 shares of the financial services provider's stock valued at $2,856,000 after buying an additional 1,395 shares in the last quarter. Capital International Sarl lifted its stake in CME Group by 19.0% in the fourth quarter. Capital International Sarl now owns 82,015 shares of the financial services provider's stock valued at $19,046,000 after buying an additional 13,095 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co boosted its holdings in shares of CME Group by 1.5% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 521,568 shares of the financial services provider's stock valued at $121,036,000 after buying an additional 7,531 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now owns 21,873 shares of the company's stock, valued at approximately $5,686,980. This trade represents a 31.37 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the company's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,076 shares of company stock worth $6,871,496. Company insiders own 0.30% of the company's stock.
Analyst Ratings Changes
CME has been the subject of a number of research analyst reports. Barclays upped their target price on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research note on Wednesday. Citigroup cut CME Group from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. JPMorgan Chase & Co. dropped their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday. Erste Group Bank raised CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Finally, Oppenheimer lifted their price objective on shares of CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a report on Friday, April 11th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, CME Group has an average rating of "Hold" and a consensus price target of $248.93.
Check Out Our Latest Stock Analysis on CME Group
CME Group Stock Performance
NASDAQ:CME traded up $2.57 during mid-day trading on Thursday, reaching $264.05. 1,347,786 shares of the company's stock were exchanged, compared to its average volume of 2,153,313. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The firm has a market capitalization of $95.15 billion, a PE ratio of 27.29, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. CME Group Inc. has a one year low of $190.70 and a one year high of $273.42. The business's fifty day simple moving average is $258.05 and its two-hundred day simple moving average is $241.21.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. Analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were given a $1.25 dividend. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.89%. This is a boost from CME Group's previous quarterly dividend of $1.15. CME Group's dividend payout ratio (DPR) is presently 51.71%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
